Description

DNA sequencing is a laboratory technique used to determine the exact sequence of bases (A, C, G, and T) in a DNA molecule. The DNA base sequence carries the information a cell needs to assemble protein and RNA molecules. DNA sequence information is important to scientists investigating the functions of genes. The global dna sequencing market is set to grow by US$ 22 billion during 2021-2027, growing at a compound annual growth rate (CAGR) of 17.6% during the forecast period, according to data and analytics company StrategyHelix.

The report provides up-to-date market size data for period 2017-2020 and forecast to 2027 covering key market aspects like sales value for dna sequencing. The global dna sequencing market is segmented on the basis of product, sequencing type, end user, and region. By product, it is categorized into sequencing services, sequencing instruments, sequencing consumables, and sequencing informatics. The sequencing services segment held the largest market share in 2020. However, the sequencing informatics segment is expected to witness the highest CAGR during the forecast period. By sequencing type, the dna sequencing market is divided into next generation sequencing (NGS), sanger sequencing, and others. The NGS segment accounted for the largest market share in 2020. Based on end user, the dna sequencing market is divided into hospitals & healthcare organizations, academics & research institutions, enterprises, and others.

The report has profiled some of the key players of the market such as Agilent Technologies Inc., Bio-Rad Laboratories Inc., Danaher Corporation, Eurofins Scientific Inc., F. Hoffmann-La Roche AG, Illumina Inc., Merck KGaA, Pacific Biosciences of California Inc., PerkinElmer Inc., Thermo Fisher Scientific Inc., BGI Group, QIAGEN N.V..

The report is an invaluable resource for companies and organizations active in this industry. It provides a cohesive picture of the dna sequencing market to help drive informed decision making for industry executives, policy makers, academic, and analysts.

Report Scope

Product: sequencing services, sequencing instruments, sequencing consumables, and sequencing informatics
Sequencing type: next generation sequencing (NGS), sanger sequencing, and others
End user: hospitals & healthcare organizations, academics & research institutions, enterprises, and others
Region: North America, Asia Pacific, Europe, and Rest of the World (ROW)
Years Considered: this report covers the period 2017 to 2027

Key Benefits for Stakeholders

Get a comprehensive picture of the global dna sequencing market
Identify regional strategies and strategic priorities on the basis of local data and analysis
Pinpoint growth sectors and trends for investment
Understand what the future of the global dna sequencing market looks like
Identify the competitive landscape and window of opportunity

Table of Contents

1. Market Definition
2. Research Methodology
3. Market Data & Outlook
3.1 Market Value
3.2 Market Value Forecast
4. DNA Sequencing Market by Product
4.1 Sequencing Services
4.2 Sequencing Instruments
4.3 Sequencing Consumables
4.4 Sequencing Informatics
5. DNA Sequencing Market by Sequencing Type
5.1 Next Generation Sequencing (Ngs)
5.2 Sanger Sequencing
5.3 Others
6. DNA Sequencing Market by End User
6.1 Hospitals & Healthcare Organizations
6.2 Academics & Research Institutions
6.3 Enterprises
6.4 Others
7. DNA Sequencing Market by Region
7.1 North America
7.2 Asia Pacific
7.3 Europe
7.4 Rest Of The World (Row)
8. Company Profiles
8.1 Agilent Technologies Inc.
8.2 Bio-Rad Laboratories Inc.
8.3 Danaher Corporation
8.4 Eurofins Scientific, Inc.
8.5 F. Hoffmann-La Roche AG
8.6 Illumina Inc.
8.7 Merck KGaA
8.8 Pacific Biosciences of California Inc.
8.9 PerkinElmer Inc.
8.10 Thermo Fisher Scientific Inc.
8.11 BGI Group
8.12 QIAGEN N.V.
9. Appendix
9.1 About StrategyHelix
9.2 Disclaimer